To address these gaps in knowledge, we performed a linear drug-target MR analysis to investigate the effects of reducing uric acid levels by XDH inhibition on the risk of ischemic diseases in individuals whose data are in the UK Biobank. The gene discussed is XDH; the disease is ischemic disease.